SCHEMBL7112651

SCHEMBL7112651

O=C(O)CCc1cnc(Br)[nH]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ PDE5A O76074 1/20 0.41
▸ PDE9A O76083 1/20 0.41
▸ P4HTM Q9NXG6 1/20 0.40
▸ GPR17 Q13304 4/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.38
▸ PRKAG1 P54619 1/20 0.38
▸ PRKAA2 P54646 1/20 0.38
▸ PRKAA1 Q13131 1/20 0.38
▸ PRKAB1 Q9Y478 1/20 0.38
▸ NR1H4 Q96RI1 1/20 0.38
▸ THRA P10827 1/20 0.37
▸ THRB P10828 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ GLA P06280 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ TBXAS1 P24557 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23824708 0.81 AOC3 (0.49) CYP1A2CYP2C9HSD17B10PDE5APDE9A
SCHEMBL18782928 0.78 CYP1A2 (0.43) CYP1A2CYP2C9HSD17B10PDE5APDE9A
SCHEMBL889024 0.77 HRH4 (0.55) CYP1A2CYP2C9HSD17B10P4HTMGPR17
SCHEMBL3396659 0.77 CYP1A2 (0.42) CYP1A2CYP2C9HSD17B10PDE5APDE9A
SCHEMBL5201259 0.74 PDE9A (0.40) CYP1A2CYP2C9HSD17B10PDE9AP4HTM
SCHEMBL7537525 0.70 AOC3 (0.46) HSD17B10MAPTTBXAS1
SCHEMBL9314265 0.69 KEAP1 (0.50) CYP1A2CYP2C9HSD17B10GPR17KDM4E
SCHEMBL26970720 0.68 TSHR (0.45) HSD17B10PDE5APDE9AP4HTMNPSR1
SCHEMBL31561464 0.67 FFAR1 (0.54) PDE5APDE9AGPR17KDM4EGLA
SCHEMBL15773979 0.67 NPSR1 (0.44) PDE5APDE9AP4HTMNPSR1THRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1350507-A1 Delivery of a substance to a pre-determinated site Applied NanoSystems B.V. (NL) 2003-10-08 — — EP disclosed
WO-1998048020-A2 MAMMALIAN UBIQUITIN-ISOPEPTIDASES THAT CONTROL CELL PROLIFERATION ISTITUTO EUROPEO DI ONCOLOGIA S.R.L. (IT) 1998-10-29 — — WO disclosed
Send feedback